Briscoe J, Guschin D, Rogers N C, Watling D, Müller M, Horn F, Heinrich P, Stark G R, Kerr I M
Imperial Cancer Research Fund, London, U.K.
Philos Trans R Soc Lond B Biol Sci. 1996 Feb 29;351(1336):167-71. doi: 10.1098/rstb.1996.0013.
The isolation and complementation of mutant human cell lines has established an essential role for the JAK (Janus kinase) family of protein tyrosine kinases and STAT (signal transduction and transcription) factors in the Interferon response pathways. Activation of STATs by JAKs occurs in receptor complexes at the cell membrane. Activated STATs form homo- or heterodimers and, with or without additional factors, migrate to the nucleus to initiate transcription. Different STAT combinations interact differentially with related DNA response elements. Signalling pathways of this novel type are likely utilized by a wide variety of polypeptide ligands. Data from the IL2, IL6 and IFN systems indicate a major role for the tyrosine phosphorylated receptor/JAK complexes (rather than substrate specificity of the JAKs per se) in STAT selection. The mutant cell lines lacking individual JAKs and STATs are being used together with kinase-negative JAK mutants which differentially affect the IFN-gamma, and IFN-alpha beta and IL-6 pathways in the further analysis of these and additional systems.
突变人类细胞系的分离与互补已证实,蛋白酪氨酸激酶的JAK(Janus激酶)家族和STAT(信号转导与转录)因子在干扰素反应途径中发挥着重要作用。JAK对STAT的激活发生在细胞膜上的受体复合物中。激活的STAT形成同二聚体或异二聚体,无论有无其他因子,都会迁移至细胞核以启动转录。不同的STAT组合与相关DNA反应元件的相互作用各不相同。这类新型信号通路可能被多种多肽配体所利用。来自白细胞介素2、白细胞介素6和干扰素系统的数据表明,酪氨酸磷酸化受体/JAK复合物(而非JAK本身的底物特异性)在STAT选择中起主要作用。缺乏单个JAK和STAT的突变细胞系正与激酶阴性JAK突变体一起用于进一步分析这些系统及其他系统,这些激酶阴性JAK突变体对干扰素-γ、干扰素-αβ和白细胞介素-6途径有不同影响。